These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 11895215

  • 21. Dose-, IGF-I- and sex-dependent changes in lipid profile and body composition during GH replacement therapy in adult onset GH deficiency.
    Abrahamsen B, Nielsen TL, Hangaard J, Gregersen G, Vahl N, Korsholm L, Hansen TB, Andersen M, Hagen C.
    Eur J Endocrinol; 2004 May; 150(5):671-9. PubMed ID: 15132723
    [Abstract] [Full Text] [Related]

  • 22. Growth hormone dose regimens in adult GH deficiency: effects on biochemical growth markers and metabolic parameters.
    Møller J, Jørgensen JO, Lauersen T, Frystyk J, Naeraa RW, Orskov H, Christiansen JS.
    Clin Endocrinol (Oxf); 1993 Oct; 39(4):403-8. PubMed ID: 7507009
    [Abstract] [Full Text] [Related]

  • 23. Recombinant growth hormone (GH) therapy in GH-deficient adults: a long-term controlled study on daily versus thrice weekly injections.
    Amato G, Mazziotti G, Di Somma C, Lalli E, De Felice G, Conte M, Rotondi M, Pietrosante M, Lombardi G, Bellastella A, Carella C, Colao A.
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3720-5. PubMed ID: 11061530
    [Abstract] [Full Text] [Related]

  • 24. Dose titration and patient selection increases the efficacy of GH replacement in severely GH deficient adults.
    Murray RD, Skillicorn CJ, Howell SJ, Lissett CA, Rahim A, Shalet SM.
    Clin Endocrinol (Oxf); 1999 Jun; 50(6):749-57. PubMed ID: 10468947
    [Abstract] [Full Text] [Related]

  • 25. IGF-I and IGF binding protein-3 levels during initial GH dosage step-up are indicators of GH sensitivity in GH-deficient children and short children born small for gestational age.
    Ranke MB, Traunecker R, Martin DD, Schweizer R, Schwarze CP, Wollmann HA, Binder G.
    Horm Res; 2005 Jun; 64(2):68-76. PubMed ID: 16113581
    [Abstract] [Full Text] [Related]

  • 26. Growth hormone (GH) provocative retesting of 108 young adults with childhood-onset GH deficiency and the diagnostic value of insulin-like growth factor I (IGF-I) and IGF-binding protein-3.
    Juul A, Kastrup KW, Pedersen SA, Skakkebaek NE.
    J Clin Endocrinol Metab; 1997 Apr; 82(4):1195-201. PubMed ID: 9100596
    [Abstract] [Full Text] [Related]

  • 27. Re-assessment of growth hormone secretion in young adult patients with childhood-onset growth hormone deficiency.
    Donaubauer J, Kiess W, Kratzsch J, Nowak T, Steinkamp H, Willgerodt H, Keller E.
    Clin Endocrinol (Oxf); 2003 Apr; 58(4):456-63. PubMed ID: 12641629
    [Abstract] [Full Text] [Related]

  • 28. Use of a GH receptor antagonist (GHRA) to explore the relationship between GH and IGF-I in adults with severe GH deficiency (GHD).
    Berg CA, Pokrajac A, Bidlingmaier M, Strasburger CJ, Shalet SM, Trainer PJ.
    Clin Endocrinol (Oxf); 2009 Mar; 70(3):439-45. PubMed ID: 19067728
    [Abstract] [Full Text] [Related]

  • 29. Adolescents with partial growth hormone (GH) deficiency develop alterations of body composition after GH discontinuation and require follow-up.
    Tauber M, Jouret B, Cartault A, Lounis N, Gayrard M, Marcouyeux C, Pienkowski C, Oliver I, Moulin P, Otal P, Joffre F, Arnaud C, Rochiccioli P.
    J Clin Endocrinol Metab; 2003 Nov; 88(11):5101-6. PubMed ID: 14602733
    [Abstract] [Full Text] [Related]

  • 30. Improvement in cardiac systolic function and reduced prevalence of metabolic syndrome after two years of growth hormone (GH) treatment in GH-deficient adult survivors of childhood-onset acute lymphoblastic leukemia.
    Follin C, Thilén U, Ahrén B, Erfurth EM.
    J Clin Endocrinol Metab; 2006 May; 91(5):1872-5. PubMed ID: 16522695
    [Abstract] [Full Text] [Related]

  • 31. The influence of gender on the short and long-term effects of growth hormone replacement on bone metabolism and bone mineral density in hypopituitary adults: a 5-year study.
    Drake WM, Rodríguez-Arnao J, Weaver JU, James IT, Coyte D, Spector TD, Besser GM, Monson JP.
    Clin Endocrinol (Oxf); 2001 Apr; 54(4):525-32. PubMed ID: 11318789
    [Abstract] [Full Text] [Related]

  • 32. Improvement in insulin sensitivity without concomitant changes in body composition and cardiovascular risk markers following fixed administration of a very low growth hormone (GH) dose in adults with severe GH deficiency.
    Yuen KC, Frystyk J, White DK, Twickler TB, Koppeschaar HP, Harris PE, Fryklund L, Murgatroyd PR, Dunger DB.
    Clin Endocrinol (Oxf); 2005 Oct; 63(4):428-36. PubMed ID: 16181235
    [Abstract] [Full Text] [Related]

  • 33. Adults with childhood-onset growth hormone deficiency: effects of growth hormone treatment on cardiac structure.
    Sartorio A, Ferrero S, Conti A, Bragato R, Malfatto G, Leonetti G, Faglia G.
    J Intern Med; 1997 Jun; 241(6):515-20. PubMed ID: 10497628
    [Abstract] [Full Text] [Related]

  • 34. Serum homocysteine concentrations in children with growth hormone (GH) deficiency before and after 12 months GH replacement.
    Esposito V, Di Biase S, Lettiero T, Labella D, Simeone R, Salerno M.
    Clin Endocrinol (Oxf); 2004 Nov; 61(5):607-11. PubMed ID: 15521964
    [Abstract] [Full Text] [Related]

  • 35. Subnormal serum insulin-like growth factor-I levels in young adults with childhood-onset nonacquired growth hormone (GH) deficiency who recover normal gh secretion may indicate less severe but persistent pituitary failure.
    Gelwane G, Garel C, Chevenne D, Armoogum P, Simon D, Czernichow P, Léger J.
    J Clin Endocrinol Metab; 2007 Oct; 92(10):3788-95. PubMed ID: 17666477
    [Abstract] [Full Text] [Related]

  • 36. Immunoblot studies of the acid-labile subunit (ALS) in biological fluids, normal human serum and in children with GH deficiency and GH receptor deficiency before and after long-term therapy with GH or IGF-I respectively.
    Labarta JI, Gargosky SE, Simpson DM, Lee PD, Argente J, Guevara-Aguirre J, Rosenfeld RG.
    Clin Endocrinol (Oxf); 1997 Dec; 47(6):657-66. PubMed ID: 9497872
    [Abstract] [Full Text] [Related]

  • 37. Skeletal effects of two years of treatment with low physiological doses of recombinant human growth hormone (GH) in patients with adult-onset GH deficiency.
    Janssen YJ, Hamdy NA, Frölich M, Roelfsema F.
    J Clin Endocrinol Metab; 1998 Jun; 83(6):2143-8. PubMed ID: 9626153
    [Abstract] [Full Text] [Related]

  • 38. Body composition, blood pressure, and lipid metabolism before and during long-term growth hormone (GH) treatment in children with short stature born small for gestational age either with or without GH deficiency.
    Sas T, Mulder P, Hokken-Koelega A.
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3786-92. PubMed ID: 11061539
    [Abstract] [Full Text] [Related]

  • 39. Effects of growth hormone replacement therapy on metabolic and cardiac parameters, in adult patients with childhood-onset growth hormone deficiency.
    Jallad RS, Liberman B, Vianna CB, Vieira ML, Ramires JA, Knoepfelmacher M.
    Growth Horm IGF Res; 2003 Oct; 13(2-3):81-8. PubMed ID: 12735929
    [Abstract] [Full Text] [Related]

  • 40. Two weeks of daily injections and continuous infusion of recombinant human growth hormone (GH) in GH-deficient adults: I. Effects on insulin-like growth factor-I (IGF-I), GH and IGF binding proteins, and glucose homeostasis.
    Johansson JO, Oscarsson J, Bjarnason R, Bengtsson BA.
    Metabolism; 1996 Mar; 45(3):362-9. PubMed ID: 8606645
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.